BioClinica, Inc. Reports 14.9% Growth in First Quarter Service Revenues

May 9, 2012 |

1 min read

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced its financial results for the first quarter ended March 31, 2012.

Earnings

MORE ON THIS TOPIC

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO tracker

Generate Clocks Largest IPO Since 2024 With $400M Raise

February 27, 2026

·

5 min read

·

Tristan Manalac

The Westin St. Francis in San Francisco, home of the J.P. Morgan Healthcare Conference.

Special edition

Deep Dive: BioSpace Takes On JPM26 in San Francisco

February 27, 2026

·

2 min read

·

Annalee Armstrong

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Viatris Will Cut Up to 10% of Global Workforce Over 3 Years

February 26, 2026

·

58 min read

·

BioSpace Editorial Staff

Control, Complex work, Businessman balancing on a ball

Deals

Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+

February 26, 2026

·

1 min read

·

Tristan Manalac